| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.12M | 1.34M | 909.60K | 539.69K | 1.26M |
| Gross Profit | 934.57K | 1.07M | -1.45M | 539.69K | 1.26M |
| EBITDA | -1.95M | -1.18M | -1.86M | -2.45M | -1.66M |
| Net Income | -2.05M | -1.31M | -1.91M | -2.67M | -1.85M |
Balance Sheet | |||||
| Total Assets | 2.25M | 4.04M | 3.85M | 5.37M | 4.55M |
| Cash, Cash Equivalents and Short-Term Investments | 664.30K | 1.99M | 2.48M | 4.23M | 3.03M |
| Total Debt | 1.17M | 1.30M | 267.72K | 464.13K | 646.22K |
| Total Liabilities | 1.32M | 1.44M | 332.79K | 569.59K | 762.06K |
| Stockholders Equity | 933.63K | 2.60M | 3.52M | 4.80M | 3.78M |
Cash Flow | |||||
| Free Cash Flow | -1.33M | -790.44K | -2.30M | -2.18M | -1.81M |
| Operating Cash Flow | -1.33M | -788.82K | -2.30M | -2.18M | -1.80M |
| Investing Cash Flow | -726.00 | -1.62K | 55.59K | 2.69M | -2.78M |
| Financing Cash Flow | 0.00 | 308.67K | 484.50K | 3.45M | 86.26K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $77.64M | 354.27 | 9.95% | ― | 2.21% | -15.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $27.86M | 1.03 | 50.99% | ― | -48.54% | ― | |
52 Neutral | $67.65M | 110.94 | 2.42% | ― | 38.22% | 70.68% | |
52 Neutral | $98.31M | -4.16 | -56.38% | ― | -15.76% | -25.27% | |
45 Neutral | $34.99M | -14.39 | -122.90% | ― | -16.49% | -59.21% |
On February 18, 2026, Research Frontiers entered into subscription agreements with private accredited investors, including family members of a company director and the owner of a licensee producing SPD-SmartGlass products, for a private placement of 1.1 million common shares at $1.00 per share, matching the February 13, 2026 closing price. The transaction provides the company with $1.1 million in proceeds and includes one warrant per share, exercisable at step-up prices between $1.10 and $1.50 through February 28, 2031, with all shares issued in the placement and upon future warrant exercise remaining unregistered and subject to at least a six-month holding period, which may affect liquidity considerations for participating investors.
The most recent analyst rating on (REFR) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Research Frontiers stock, see the REFR Stock Forecast page.